Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article
Yes, It is official! Buried down under in a filing late last week, Taro, nonchalantly confirmed that it is now the Number 1 Generic Dermatology firm in the USA in Sales. Shareholders it is time to celebrate and be proud of this. You own an unique, invaluable asset in the market place: A Market Leader in a fundamentally favorable, limited competition business.
If you like to receive free updates on stocks directly to your email inbox, click on the subscribe via mail icon situated on the top right of this blog.